Literature DB >> 3298431

Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).

R T Coughlin, W C Bogard.   

Abstract

The antigen specificity of two immunoprotective monoclonal antibodies derived from mice immunized with Escherichia coli 0111:B4 bacteria and boosted with purified lipopolysaccharide (LPS) were investigated. One of the antibodies, B7, was shown by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunostaining to bind to the O-antigen containing LPS species, whereas the other antibody, 5B10, reacted with both O-antigen containing homologs and the O-antigen-deficient LPS. 5B10 did not bind to LPS from E. coli J5, an Rc mutant of E. coli 0111:B4 that lacks both the O-antigen and outer core sugars. 5B10 did not cross-react with LPS from several other E. coli strains. Thus 5B10 appeared to recognize a type-specific epitope in the outer core of LPS exclusive of Rc determinants. The monoclonal antibody specific for the polymeric O-antigen is of the IgG3 subclass, and the monoclonal antibody 5B10 specific for the outer core of LPS is an IgG2a. Although B7 and 5B10 were equally able to protect mice from a lethal challenge of E. coli 0111:B4 organisms, the outer core-specific IgG2a antibody was much more efficient at mediating the binding of human complement C3 than the O-antigen-specific IgG3 monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298431

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

4.  Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Authors:  Joseph Horzempa; Thomas K Held; Alan S Cross; Dana Furst; Mohammed Qutyan; Alice N Neely; Peter Castric
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

5.  Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain.

Authors:  Y Fujihara; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Authors:  M A Mascelli; B Frederick; T Ely; D S Neblock; D J Shealy; K Y Pak; P E Daddona
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Terashima; I Uezumi; T Tomio; M Kato; K Irie; T Okuda; S Yokota; H Noguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection.

Authors:  R C Harmon; R L Rutherford; H M Wu; M S Collins
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.